Clinical Trial Update: The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the immunogenicity and safety of Zostavax and Shingrix in rheumatoid arthritis patients treated with abatacept. The study status is ACT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster
• Rheumatoid Arthritis

Drugs mentioned

• ORENCIA (ABATACEPT)
• Shingrix (recombinant zoster vaccine, adjuvanted)
• Zostavax (Varicella zoster vaccine live)

Snippet

Sponsor: Kevin Winthrop | Conditions: Herpes Zoster, Inflammatory Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING